Clinical complications of Densiron 68 intraocular tamponade for complicated retinal detachment

Eye

Volumn 24, Issue 1, 2010, Pages 21-28

  Li, W ^a   Zheng, J ^a   Zheng, Q ^a   Wu, R ^a   Wang, X ^a   Xu, M ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Complications; Densiron 68; Proliferative vitreoretinopathy; Retinal detachment; Silicone oil; Vitrectomy

Indexed keywords

ADULT; AGED; ARTICLE; BODY POSTURE; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; EYE INFLAMMATION; FEMALE; HUMAN; INCIDENCE; INTRAOCULAR PRESSURE ABNORMALITY; MALE; POSTOPERATIVE COMPLICATION; RETINA DETACHMENT; RETINA DISEASE; RETINA SURGERY; TREATMENT OUTCOME; VISUAL ACUITY; VITREORETINOPATHY;

EID: 75449119467     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2009.57     Document Type: Article

References (27)

1. Ah-Fat FG, Sharma MC, Majid MA, McGalliard JN, Wong D. Trends in vitreoretinal surgery at a tertiary referral centre: 1987 to 1996. Br J Ophthalmol 1999; 83(4): 396-398.
2. Tabandeh H, Sullivan PM, Smahliuk P, Flynn Jr HW, Schiffman J. Suprachoroidal hemorrhage during pars plana vitrectomy. Risk factors and outcomes. Ophthalmology 1999; 106(2): 236-242.
3. Fison PN, Chignell AH. Diplopia after retinal detachment surgery. Br J Ophthalmol 1987; 71(7): 521-525.
4. Flindall RJ, Norton EW, Curtin VT, Gass JD. Reduction of extrusion and infection following episcleral silicone implants and cryopexy in retinal detachment surgery. Am J Ophthalmol 1971; 71(4): 835-837.
5. Kwartz J, Charles S, McCormack P, Jackson A, Lavin M. Anterior segment ischaemia following segmental scleral buckling. Br J Ophthalmol 1994; 78(5): 409-410.
6. McCuen II BW, Azen SP, Stern W, Lai MY, Lean JS, Linton KL et al. Vitrectomy with silicone oil or perfluoropropane gas in eyes with severe proliferative vitreoretinopathy. Silicone Study Report 3. Retina 1993; 13(4): 279-284.
7. Kirchhof B, Wong D, Van Meurs J, Hilgers RD, Macek M, Lois N et al. Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 2002; 133: 95-101.
8. Chang S, Sparrow JR, Iwamoto T, Gershbein A, Ross R, Ortiz R. Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid. Retina. 1991; 11(4): 367-374.
9. Martinez-Reina MJ, Ruiz-Moreno JM, Montero JA, Rueda J. Histopathology and ultrastructure of rabbit retina after intravitreous injection of perfluorohexyloctane (F6H8). Curr Eye Res 2005; 30(9): 773-779.
10. Hiscott P, Magee RM, Colthurst M, Lois N, Wong D. Clinicopathological correlation of epiretinal membranes and posterior lens opacification following perfluorohexyloctane tamponade. Br J Ophthalmol 2001; 85(2): 179-183.
11. Wong D, Van Meurs JC, Stappler T, Groenewald C, Pearce IA, McGalliard JN et al. A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent. Br J Ophthalmol 2005; 89(6): 662-665.
12. Sandner D, , Herbrig E, , Engelmann K. High-density silicone oil (Densiron) as a primary intraocular tamponade: 12-month follow up. Graefes Arch Clin Exp Ophthalmol 2007; 245(8): 1097-1105.
13. Theelen T, Tilanus MA, Klevering BJ. Intraocular inflammation following endotamponade with high-density silicone oil. Graefes Arch Clin Exp Ophthalmol 2004; 242(7): 617-620.
14. Majid MA, Hussin HM, Biswas S, Haynes RJ, Mayer EJ, Dick AD. Emulsification of Densiron-68 used in inferior retinal detachment surgery. Eye 2008; 22(1): 152-157.
15. Gerding H, Kolck A. Perfluorohexyloctane as internal tamponade in patients with complicated retinal detachment. Results after 6 months. Ophthalmologe 2004; 101(3): 255-262.
16. Roider J, Hoerauf H, Kobuch K, Gabel VP. Clinical findings on the use of long-term heavy tamponades (semifluorinated alkanes and their oligomers) in complicated retinal detachment surgery. Graefes Arch Clin Exp Ophthalmol 2002; 240(12): 965-971.
17. Vote B, Wheen L, Cluroe A, Teoh H, McGeorge A. Further evidence for proinflammatory nature of perfluorohexyloctane in the eye. Clin Experiment Ophthalmol 2003; 31(5): 408-414.
18. Herbrig E, Sandner D, Engelmann K. Anatomical and functional results of endotamponade with heavy silicone oil-Densiron 68-in complicated retinal detachment. Ophthalmic Res 2007; 39(4): 198-206.
19. Sandner D, Engelmann K. First experiences with highdensity silicone oil (Densiron) as an intraocular tamponade in complex retinal detachment. Graefes Arch Clin Exp Ophthalmol 2006; 244(5): 609-619.
20. Stefaniotou MI, Aspiotis MV, Kitsos GD, Kalogeropoulos CD, Asproudis IC, Psilas KG. Our experience with perfluorohexyloctane (F6H8) as a temporary endotamponade in vitreoretinal surgery. Eur J Ophthalmol 2002; 12(6): 518-522.
21. Stappler T, Heimann H,Wong D, Gibran SK, Groenewald C, Pearce IA. Heavy tamponade 2 Densiron 68(R) in routine clinical practice: anatomical and functional outcomes of a consecutive case series. Eye 2008; 22(10): 1360-1365.
22. Lim BL, Vote B. Densiron intraocular tamponade: a case series. Clin Experiment Ophthalmol 2008; 36(3): 261-264.
23. Bottoni F, Sborgia M, Arpa P, De Casa N, Bertazzi E, Monticelli M et al. Perfluorocarbon liquids as postoperative short-term vitreous substitutes in complicated retinal detachment. Graefes Arch Clin Exp Ophthalmol 1993; 231(11): 619-628.
24. Wong D, Kumar I, Quah SA, Ali H, Valdeperas X, Romano MR. Comparison of postoperative intraocular pressure in patients with Densiron-68 vs conventional silicone oil: a case-control study. Eye 2007; 23(1): 190-194.
25. Scott IU, Flynn Jr HW, Murray TG, Feuer WJ, Perfluoron study group. Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study. Am J Ophthalmol 2003; 136(3): 454-463.
26. Wickham L, Asaria RH, Alexander R, Luthert P, Charteris DG. Immunopathology of intraocular silicone oil: enucleated eyes. Br J Ophthalmol 2007; 91(2): 253-257.
27. Wong D, Cazabon S, Ali H, Kumar I, Valldeperas X, Groenewald C et al. Can the sequential use of conventional silicone oil and heavy oil be a strategy for the management of proliferative vitreoretinopathy? Ann Acad Med Singapore 2006; 35(3): 181-184.